Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

miR-491-5p inhibits Emilin 1 to promote fibroblasts proliferation and fibrosis in gluteal muscle contracture via TGF-Beta1/Smad2 pathway

S. Chen, Q. Wu, Y. Wang, J. Xu, Y. Wang, X. Luo

. 2022 ; 71 (2) : 219-231. [pub] 20220411

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22014567

Gluteal muscle contracture (GMC) is a chronic fibrotic disease of gluteal muscles due to multiple etiologies. Emilin 1 plays a determinant role in fibers formation, but its role in the progression of GMC remains unclear. The present study was aimed to search for the predictive role and regulatory mechanism of Emilin 1 on GMC. Here, Protein and mRNA expression of Emilin 1 were decreased in GMC tissues compared to normal muscle tissues. Using the anslysis of target prediction, Emilin 1 was observed to be a potential downstream sponge of miR-491-5p. In comparison to Emilin 1, miR-491-5p showed a aberrant elevation in GMC tissues, which was further proven to have a negative correlation with Emilin 1. The direct binding of miR-491-5p to Emilin 1 mRNA was confirmed by luciferase reporter gene assay, and miR-491-5p mimics inhibited, while miR-491-5p inhibitor promoted the protein expression and secretion of Emilin 1 in contraction bands (CB) fibroblasts. Additionally, miR-491-5p mimics promoted the expression of cyclin-dependent kinase 2 and cyclin D1 and the proliferation of CB fibroblasts, which could be reversed by Emilin 1 overexpression. Mechanistically, miR-491-5p mimics possibly activated transforming growth factor beta1 (TGF-beta1)/Smad3 signal cascade via binding to 3'-untranslated region of Emilin 1 mRNA, thereby promoting the progression of fibrosis of CB fibroblasts. Collectively, miR-491-5p inhibited Emilin 1 expression, and subsequently promoted CB fibroblasts proliferation and fibrosis via activating TGF-beta1/Smad3 signal axis. MiR-491-5p might be a potentially effective biomarker for predicting GMC, providing a novel therapeutic strategy for GMC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22014567
003      
CZ-PrNML
005      
20230403095325.0
007      
ta
008      
220602s2022 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934804 $2 doi
035    __
$a (PubMed)35275699
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Chen, Shuai $u Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China $u Xiamen Key Laboratory of Otolaryngology Head and Neck Surgery, Xiamen, China
245    10
$a miR-491-5p inhibits Emilin 1 to promote fibroblasts proliferation and fibrosis in gluteal muscle contracture via TGF-Beta1/Smad2 pathway / $c S. Chen, Q. Wu, Y. Wang, J. Xu, Y. Wang, X. Luo
520    9_
$a Gluteal muscle contracture (GMC) is a chronic fibrotic disease of gluteal muscles due to multiple etiologies. Emilin 1 plays a determinant role in fibers formation, but its role in the progression of GMC remains unclear. The present study was aimed to search for the predictive role and regulatory mechanism of Emilin 1 on GMC. Here, Protein and mRNA expression of Emilin 1 were decreased in GMC tissues compared to normal muscle tissues. Using the anslysis of target prediction, Emilin 1 was observed to be a potential downstream sponge of miR-491-5p. In comparison to Emilin 1, miR-491-5p showed a aberrant elevation in GMC tissues, which was further proven to have a negative correlation with Emilin 1. The direct binding of miR-491-5p to Emilin 1 mRNA was confirmed by luciferase reporter gene assay, and miR-491-5p mimics inhibited, while miR-491-5p inhibitor promoted the protein expression and secretion of Emilin 1 in contraction bands (CB) fibroblasts. Additionally, miR-491-5p mimics promoted the expression of cyclin-dependent kinase 2 and cyclin D1 and the proliferation of CB fibroblasts, which could be reversed by Emilin 1 overexpression. Mechanistically, miR-491-5p mimics possibly activated transforming growth factor beta1 (TGF-beta1)/Smad3 signal cascade via binding to 3'-untranslated region of Emilin 1 mRNA, thereby promoting the progression of fibrosis of CB fibroblasts. Collectively, miR-491-5p inhibited Emilin 1 expression, and subsequently promoted CB fibroblasts proliferation and fibrosis via activating TGF-beta1/Smad3 signal axis. MiR-491-5p might be a potentially effective biomarker for predicting GMC, providing a novel therapeutic strategy for GMC.
650    _2
$a proliferace buněk $7 D049109
650    12
$a kontraktura $x patologie $7 D003286
650    _2
$a fibroblasty $x metabolismus $7 D005347
650    _2
$a fibróza $7 D005355
650    _2
$a lidé $7 D006801
650    _2
$a membránové glykoproteiny $7 D008562
650    12
$a mikro RNA $x genetika $x metabolismus $7 D035683
650    _2
$a kosterní svaly $x metabolismus $7 D018482
650    _2
$a messenger RNA $x metabolismus $7 D012333
650    _2
$a protein Smad2 $x metabolismus $7 D051899
650    _2
$a transformující růstový faktor beta1 $x genetika $7 D053773
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wu, Qiuwan $u Department Science and Technology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
700    1_
$a Wang, Yang $u Sports Department of Tianjin Cheng Jian University, Tianjin, China
700    1_
$a Xu, Jie $u Department of Science and Technology, Tianjin University of Sport, Tianjin, China
700    1_
$a Wang, Ye $u Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China $u Xiamen Key Laboratory of Otolaryngology Head and Neck Surgery, Xiamen, China
700    1_
$a Luo, Xianyang $u Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China $u Xiamen Key Laboratory of Otolaryngology Head and Neck Surgery, Xiamen, China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 2 (2022), s. 219-231
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35275699 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220602 $b ABA008
991    __
$a 20230403095323 $b ABA008
999    __
$a ok $b bmc $g 1824822 $s 1165788
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 71 $c 2 $d 219-231 $e 20220411 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20220602

Find record

Citation metrics

Archiving options